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ABSTRACT
A 34 year-old Afro-Caribbean female presented with recurring episodes of fever and lower abdominal pain over a period of two months 
not improving despite courses of antibiotics for possible recurrent urinary tract infections. On admission to hospital, patient was treated 
for a possible pyelonephritis or pelvic inflammatory disease (PID). Extensive investigations into possible source of infection were carried 
out. However, all of the repeated microbiological cultures were normal. Patient was investigated further for other possible causes including 
connective tissue disease, haematological disorders, or neoplasm, all of which were normal. Diagnosis of adult onset Still’s disease (AOSD) 
was confirmed by a rheumatologist based on Yamaguchi’s diagnostic criteria for AOSD alongside significantly raised serum ferritin. Patient 
was treated with steroids to which she showed remarkable clinical improvement alongside marked reduction in her serum ferritin levels. 
LEARNING POINTS
• The four giant causes of fever of unknown origin are: infections, connective tissue diseases, haematological disorders, and malignancies. 
•  AOSD is a diagnosis of exclusion using Yamaguchi criteria alongside raised ferritin levels (the most sensitive biomarker). 
•  Most AOSD patients will respond to steroid treatment. However, approximately one third of the patients require further 
immunosuppression to achieve disease remission. 
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INTRODUCTION
AOSD is a rare multi-system inflammatory disorder. The typical clinical triad of AOSD is cyclical high grade fever, arthralgia, and rash[1]. All 
cases reported in the literature presented with a minimum of fever and arthralgia/arthritis alongside other variable systematic effects[2]. 
The case presented in this article depicts the challenge of making a confirmed diagnosis of AOSD in a patient initially presenting atypically 
with mild lower abdominal pain and fever of unknown origin in the absence of arthralgia or joint involvement. The diagnosis of AOSD 
was reached after conducting a series of investigations that ruled out any infectious, autoimmune, haematological, or neoplastic causes 
of pyrexia of unknown origin. Diagnosis was made on the basis of the clinically-approved Yamaguchi criteria for the diagnosis of AOSD 
alongside significantly raised serum ferritin[3].
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CASE DESCRIPTION 
A 34 year-old Afro-Caribbean presented at the emergency department with a 2 month history of fever and mild lower abdominal pain. 
She was initially treated in the community for recurrent urinary tract infections but her symptoms persisted so she self-presented to the 
emergency department. Patient reported gradual onset of fever and intermittent lower abdominal pain. Patient also recently developed 
a sore throat for which she was treated in the community for upper respiratory tract infection. Patient denied any genitourinary tract 
symptoms. Patient neither had any changes in her bowel habit throughout her illness period nor did she experience any per rectum bleeding. 
Patient had no respiratory or neurological symptom and denied any rash, weight loss, night sweats, arthralgia, or lumps or bumps anywhere 
in her body. Patient is married and has one child. Last menstrual period was one week prior to her admission. Patient had been to France with 
her family 3 weeks prior to her presentation. She declined any illness or exposure to ill people while abroad. There was no other recent travel 
history. She was otherwise medically fit and takes no regular medications. She denied taking or injecting any illicit drugs. There was no family 
history of recent illness, connective tissue, haematological diseases, or malignancies. 
Patient was alert on clinical examination with no pallor, jaundice, cyanosis, or clubbing. Vital signs on admission showed temperature of 39.4 
degrees and tachycardia at 126 beats per minute, otherwise normal respiratory rate, blood pressure, and oxygen saturation of 99% on air. 
Patient was noted to have enlarged cervical lymph nodes but normal palpation of other lymph node groups. Cardio-respiratory examinations 
were unremarkable and abdomen was soft with mild suprapubic tenderness in the absence of any organ enlargement, guarding, or rebound 
tenderness with normal bowel sounds on auscultation. No focal neurology or any signs of meningism (Fig. 1). 
Figure 1. Cyclical pattern of patient high grade fever alongside the other vital signs through the first five days of patient admission.
Methods and procedures 
Initial investigations revealed normal Chest X-ray and normal urine analysis. Routine bloods showed moderately raised inflammatory 
markers with mildly deranged liver function test. Patient was initially treated for suspected genitourinary sepsis (possible pyelonephritis or 
PID) by intravenous fluids and antibiotics. Patient was then reviewed by the gynaecology team (on basis of a suspected diagnosis of PID 
as well as a positive beta human chorionic gonadatropin (beta-HCG). Trans-vaginal ultrasound scan was performed urgently and showed 
normal examination with no products of conception ruling out pregnancy or any other gynaecological disease.  
Patient continued to spike temperature despite using different IV broad spectrum antibiotics for pyrexia of unknown origin as per the 
recommendations of the local microbiologist.
All microbiological investigations were normal including respiratory, urinary, and stool cultures as well as gynaecological swab cultures. 
Full bacterial and viral screen for persistent fever were normal (including HIV and hepatitis). Patient also had normal Sickle cell and 
haemoglobinopathy screen, immunological screen, and rheumatoid arthritis screen. Patient was noted to have positive anti-nucleic acid 
(ANA) antibodies with normal lupus screen, ANCA and ENA antibodies. Trans-thoracic echo scan was performed which ruled out any 
vegetation with normal heart structures. Computed tomography (CT) of the chest, abdomen, and pelvis was performed which showed no 
focus of infection or malignancy explaining the persistent fever. A haematologist reviewed the patient and performed a bone biopsy, which 
showed normal bone marrow cells in the absence of malignant cells.  
Patient found to have significantly raised serum ferritin (47869 µg/L) with raised erythrocyte sedimentation rate (ESR) as well as lactate 
dehydrogenase (LDH 2000 units/litres). Patient symptoms, signs, and investigations scored only one out of eleven (for positive ANA) on the 
American college of rheumatology criteria for systemic lupus erythromatosis (SLE), excluding a diagnosis of SLE. Patient neither exhibited 
changes in her bowel habit throughout her illness period nor did she notice any blood or mucous in her faeces. Patient neither showed 
symptoms suggesting intestinal malabsorption nor did she have any extra-intestinal features that could point to a diagnosis of inflammatory 
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bowel disease (IBD). The lack of the cardinal clinical features of IBD alongside the significantly raised ferritin with normal CT abdomen and 
pelvis made a diagnosis of IBD very unlikely[4-6].
Patient was stable and was discharged on regular paracetamol and ibuprofen. Initial diagnosis was pyrexia of unknown origin after all of the 
repeatedly normal microbiological and immunological investigations alongside full body CT scan and bone biopsy. Patient was reviewed in 
outpatient clinic one week post discharge where she was readmitted again with persistent fever. Full microbiological work-up was repeated 
and was normal. A diagnosis of exclusion of AOSD was reached and confirmed by a rheumatologist using Yamaguchi diagnostic criteria 
alongside the significantly raised serum ferritin as well ESR and LDH[3]. Patient satisfied two major criteria (fever of more than 39° Celsius 
lasting more than a week alongside leucocytosis with more than 80% polymorphoneuclear cells) in addition to 3 minor criteria (sore throat, 
lymphadenopathy, and deranged liver function). All the antibiotics were stopped and patient was started on high-dose prednisolone, to which 
patient responded remarkably well and so steroids were tapered over four weeks. Patient improved significantly when she was reviewed 
in the rheumatology outpatient clinic. Patient was explained the possible need for disease modifying anti-rheumatic drugs (DMARDs) if her 
symptoms relapse again in the future.
DISCUSSION
Adult onset Still’s disease (AOSD) is a rare multisystem inflammatory disease first described by Bywaters in 1971 after studying 17 patients 
presenting with similar features to Still’s disease in children[7,8]. AOSD tends to affect young adults (most commonly 16-35 years olds) and 
has an annual incidence rate of less than 1 in 100,000. It affects both genders equally[8, 9]. 
There is no known cause but it is believed that its aetiology is multifactorial with a combination of genetic and environmental (mainly 
infectious) factors having been identified[10]. AOSD is still a diagnostic challenge to most physicians and this diagnosis has been reached 
by exclusion in most reported cases. The most commonly used diagnostic criteria to help establish a diagnosis of AOSD was developed by 
Yamaguchi et al.[3]. For an AOSD diagnosis to be confirmed against Yamaguchi’s diagnostic criteria, the patient must have a minimum of two 
major criteria and three minor criteria. 
A major systematic review of AOSD by Ohta et al. revealed that all of their 228 reported AOSD cases presented with arthralgia except for 
one particular case[11]. This case was originally reported by Bywaters in 1971 but no details of the associated symptoms and signs were 
provided[8]. In addition, 13% of the 228 cases reported by Ohta et al presented with abdominal pain without clear details on whether or not 
any case had abdominal pain associated with joint involvement in the initial presentation[11].
Treatment of AOSD usually starts with non-steroidal anti-inflammatory drugs (NSAIDs) with around 80% of patients requiring steroids 
to achieve full recovery. Approximately 35% of patients require DMARDs such as methotrexate, azathioprine, cyclosporine, and 
cylclophosphamide as maintenance therapy to combat the disease[13]. There is good evidence supporting the use of biological agents (mainly 
anti-TNF agents such us infliximab and etanercept) especially in refractory AOSD patients[13-15].
Most patients diagnosed with AOSD recovered well and their function returned to normal. However, a consistent finding in the literature is 
that approximately one third of ASOD patients develop erosive Rheumatoid pattern polyarthritis[11-15]. This emphasises the importance of 
considering early AOSD diagnosis in any patient admitted with pyrexia of unknown origin with normal microbiological, autoimmune screen, 
body imaging, and bone marrow biopsy.  
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